Tag: Policy + Advocacy Updates

On November 13, 2025, CBSA held its 22nd Annual Awards Celebration Presented by AGC Biologics. This annual celebration highlights the spirit and drive of Colorado’s vibrant life sciences ecosystem, br...

This past week, the Biotechnology Innovation Organization (BIO) hosted its annual patient advocacy summit, the Patient Advocacy Changemakers Event (PACE), in Washington, D.C. The theme for this year’s...

On October 3, despite hearing testimony from a variety of stakeholders (including CBSA) expressing significant concerns, the Colorado Prescription Drug Affordability Board (PDAB or Board) set its firs...

As the federal government shuts down following the failure of Congress to agree on how to fund the government (with healthcare standing out as a flashpoint), and after the Trump Administration instruc...

This week’s policy blog includes federal and state updates on topics relevant to Colorado’s life sciences ecosystem:  Reauthorization of SBIR/STTR Programs  Colorado’s Budget Shortfall and S...

In recent weeks, CBSA’s Policy + Advocacy team has continued to strengthen our relationships with and showcase Colorado’s life sciences ecosystem to our state and federal legislators, legislative/cong...

On July 11, the Colorado Prescription Drug Affordability Board (PDAB or Board) held its second upper payment limit (UPL) rulemaking hearing for the autoimmune drug Enbrel, moving closer to becoming th...

This week’s policy blog includes updates on federal and state legislation and actions that will impact Colorado’s life sciences, public health, and healthcare landscape:  Federal Budget Reconcili...

This past week, the CBSA team represented our community at the BIO International Convention, shared our expertise on the Colorado Prescription Drug Affordability Board (PDAB) during a webinar hosted b...

Of the 26 bills relevant to Colorado’s life sciences ecosystem and the patients it serves that CBSA tracked during Colorado’s 2025 legislative session, Governor Polis has now signed into law all 22 bi...